Elanco Animal Health Incorporated (NYSE: ELAN) today announced the U.S. Food and Drug Administration (FDA) has approved Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets), becoming the broadest approved canine oral parasiticide with its protection against six types of parasites—fleas, ticks, heartworms, and the three risky intestinal parasites—roundworms, hookwormsii and tapeworms. Credelio Quattro is a single, monthly chewable tablet for dogs eight weeks of age or older.
„Zoonotic disease is more common than many might think. One of our own Elanco veterinarians recently found echinococcus tapeworm lurking in her back yard,“ said Dr. David Gosche, veterinarian and U.S. Pet Health Medical Director at Elanco. „Zoonotic disease affects millions of people and animals worldwide each year. Our pets can easily serve as the ‚bridge hosts,‘ bringing these parasites into our homes when they cuddle with us on couches or in our beds—making it very easy to go from ‚ick‘ to ’sick.‘ That’s why we recommend year-round treatment with the broad spectrum parasite protection in Credelio Quattro.“
